Government Policy Makes Psychedelics Research ‘Extremely Hard,’ Top Federal Drug Official Says

Government Policy Makes Psychedelics Research ‘Extremely Hard,’ Top Federal Drug Official Says
MJ moment

Top federal drug officials are again making clear that the Schedule I status of substances like marijuana and certain psychedelics is inhibiting valuable research into their therapeutic potential. Over the course of a two-day event last week organized by the National Academies of Sciences, Engineering and Medicine that focused on psychedelics treatment, two key officials weighed in on the challenges that scientists face when applying to conduct research into Schedule I drugs, even as interest among investigators continues to increase. Conventional medications for mental illness often fail to adequately relieve patients of disabling symptoms. Join the @NASEM_Health #NeuroForum March 29-30 for a workshop on the use of psychedelics and entactogens to combat mental illness. Register. https://t.co/t10odMB0UJ — Mental Health NIMH (@NIMHgov) March 15, 2022 National Institute on Drug Abuse (NIDA) Direct Nora Volkow has consistently addressed the onerous process that researchers must go through in order to obtain these strictly controlled substances. As a scientist herself, she said she’s personally reluctant to take up research initiatives involving Schedule I substances, even as there’s growing public interest in exploring these alternative therapies. “The scheduling process makes it extremely hard to do research and it has slowed down the process enormously,” Volkow said at last week’s event. “We need to work together both with the FDA and the DEA to ensure ways that we can carry on research on Schedule I substances without having to go through the procedures that are entailed for someone that is actually using these drugs for other purposes.” The official also talked about how changing federal rules can help scientists get access to a broader the pool of substances to research, from more sources. “By being able to change the current laws for Schedule I substances for research, we can hopefully expand access to drugs that come…

Excerpt only …
READ MORE BELOW
Source : Government Policy Makes Psychedelics Research ‘Extremely Hard,’ Top Federal Drug Official Says

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.